Healthcare & Medical Tenders & Grants

Procurement opportunities and grant funding across healthcare — medical devices, pharmaceuticals, clinical services, hospital construction, health information systems, and public-health programming. Curated for medical suppliers, pharma distributors, health-tech vendors and clinical service providers.

39,885 open opportunities in this category

Who this is for

Medical device suppliers, pharmaceutical distributors, hospital operators, health-tech vendors, clinical research organisations, public-health NGOs.

Top Funders

Major sources of procurement and grant funding in this category:

WHO

World Health Organization technical assistance and emergency procurement.

See live opportunities →

Global Fund

HIV, TB and malaria programmes — major commodity procurement.

See live opportunities →

Gavi

Vaccine procurement for lower-income countries.

See live opportunities →

UNICEF Supply

Vaccines, cold chain, nutrition and child-health supplies.

See live opportunities →

World Bank

Health systems strengthening and pandemic preparedness lending.

See live opportunities →

BMGF

Bill & Melinda Gates Foundation — global health grants and procurement.

See live opportunities →

Get Healthcare & Medical Alerts

A weekly digest of only healthcare & medical tenders and grants for where you do business.

Set Up Alerts

Healthcare & Medical Opportunities

Here is a selection of recent tenders and grants. Register for free to view all healthcare & medical opportunities.

Healthcare & Medical Tenders

Supply of schools laboratory equipment and supplies

RFQ Open

Tanzania, Dodoma 1 Oct 2026 (Closes in 2 days) S.5865/2026/2027/G/04-S001

Supply of schools laboratory equipment and supplies

View Details

Supply of schools laboratory equipment and supplies

RFQ Open

Tanzania, Simiyu 1 Oct 2026 (Closes in 2 days) S.2644/2026/2027/G/03-S002

Supply of schools laboratory equipment and supplies

View Details

Supply of office consumables and stationeries

RFQ Open

Tanzania, Pwani 1 Oct 2026 (Closes in 2 days) 102607-9/2026/2027/G/08-S001

Supply of office consumables and stationeries

View Details

Electrophysiology Consumables

TENDER Open

Canada, Ontario 26 Oct 2026 (Closes in 28 days) 2526-274-2-41836728

2526-274-2 Closing Date: 10/26/2026 02:00:00 PM ET Detail: This Request for Proposal (“RFP”) is issued by UHN for the purpose of soliciting Proposals from interested Proponents for the provision of Electrophysiology Consumables to UHN and, at its option, other Purchasers. UHN intends to establish a multi-supplier arrangement and may designate one or more Primary Proponents. While not guaranteed...

View Details

35006126 - Laboratory Services

TENDER Open

New Zealand, Canterbury 30 Oct 2026 (Closes in 32 days) 35006126

Canterbury Regional Council is seeking proposals from experienced laboratory service providers to deliver reliable, timely and defensible environmental analysis across groundwater, surface water, soil, air, sediment and biota.This significant, long-term opportunity will support critical environmental monitoring, regulatory and compliance activities across Canterbury. The successful supplier wil...

View Details

Immunology MSC REVISED Pre-Market Engagement 2026/2027

TENDER Open

United Kingdom 8 Oct 2026 (Closes in 9 days) C473334

Prospective tender project to set up new managed service contract, covering equipment and products for us in Immunology labs.

View Details

JPMC Medical and Laboratory Gases

TENDER Open

United States, Illinois 20 Oct 2026 (Closes in 22 days) 27-416CMS-BOSS4-B-52903

View Details

Lifelike High Fidelity Simulation Manikins x 5

TENDER Open

Australia, Western Australia 7 Oct 2026 (Closes in 9 days) WA-NMTAFEP2026032

Agency: North Metropolitan TAFE. Category: Medical Equipment and Accessories and Supplies. Type: Tender

View Details

Bpd ammunition

TENDER Open

United States, Massachusetts 7 Oct 2026 (Closes in 8 days) BD-27-1142-143-143-133521

View Details

RFGP 6291 - Oregon Health Plan Health System Navigation Grant Program

TENDER Open

United States, Oregon 3 Nov 2026 (Closes in 36 days) S-44300-00017979

View Details

RFP 6300 - Commercial Tobacco Prevention and Cessation Communications Strategy and Services

RFP Open

United States, Oregon 19 Oct 2026 (Closes in 21 days) S-44300-00015366

View Details

Rfr 2026 doi 006 third referee appointee

TENDER Open

United States, Massachusetts 16 Oct 2026 (Closes in 18 days) BD-27-1027-1FED-1FED-133333

View Details

HCC - 09/26 - Provision of Reablement Services

TENDER Open

United Kingdom 8 Oct 2026 (Closes in 9 days) HCC2618115 - HCC2618125

Hertfordshire County Council is currently out to procurement for the Provision of Reablement Services. Reablement Services provide short-term support to Individuals in their homes. This can be following hospital discharge, illness, or acute episode, or for people who are new to care. Reablement Services aim to restore confidence and independence. The Council takes a “Reablement First” approach ...

View Details

Kununurra Hospital Fire Indicator Panel and Associated Systems

TENDER Open

Australia, Western Australia 2 Oct 2026 (Closes in 4 days) WA-WACHS202615499

Agency: WA Country Health Service. Category: Building and Facility Construction and Maintenance Services. Type: Tender

View Details

RFP - Pharmacy Benefit Managers Oversight and Reform Implementation Services

RFP Open

United States, Illinois 30 Sep 2026 (Closes tomorrow) 26-446DOI-FINAD-B-50721

View Details

RFP for Respirator Fit Testing Services

RFP Open

United States, Oregon 2 Oct 2026 (Closes in 4 days) S-44300-00012830

View Details

Inpatient Forensic Evaluation Master Service Agreement

TENDER Open

United States, Massachusetts 30 Jun 2111 (No end date) S11950-vCurrent

View Details

Request for Applications for Nursing Facilities to Provide Specialized Ventilator-Dependent Services

TENDER Open

United States, Massachusetts 22 Jan 2030 (Closes in 1212 days) S115453-vCurrent

View Details

Catering Services, Conference Space, and Hotel Accommodations RFR

TENDER Open

United States, Massachusetts 31 Dec 2026 (Closes in 94 days) BD-16-1022-DMH08-8210B-00000006867

View Details

Respite Services - Master Agreement Request for Applications

TENDER Open

United States, Massachusetts 30 Jun 2027 (Closes in 275 days) BD-18-1022-DMH08-8220A-18593

View Details

Medical and Psychological Consultative Evaluations

TENDER Open

United States, Massachusetts 30 Jun 2032 (Closes 2032) BD-21-1071-DDS-MEDR1-63004

View Details

Request for Response for Camps for Department of Mental Health Referred Children Master Agreement

TENDER Open

United States, Massachusetts 1 Jun 2036 (Closes 2036) BD-26-1022-DMH08-8210C-121465

View Details

Notice of Intent to Reprocure Recovery Learning Community (RLC)

TENDER Open

United States, Massachusetts 28 Feb 2027 (Closes in 153 days) BD-26-1022-DMH08-8220A-127701

View Details

Respite services request for response

TENDER Open

United States, Massachusetts 31 Mar 2027 (Closes in 184 days) BD-27-1022-DMH08-8220A-132190

View Details

Peer respite services: Request for response

TENDER Open

United States, Massachusetts 31 Mar 2027 (Closes in 184 days) BD-27-1022-DMH08-8220A-132193

View Details

Healthcare & Medical Grants

Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator

Open US CDC-RFA-DP-26-0227

United States

Alzheimer's disease, the most common form of dementia, is a progressive condition. It begins with mild memory loss and may lead to the inability to communicate or respond to one's environment. Its prevalence is rising with the aging U.S. population. In 2021, it was the 5th leading cause of death for those 65 and older, with death rates continuing to climb.The CDC Alzheimer's Disease Program, through the National Healthy Brain Initiative (HBI) and funded partners, promotes brain health, addresses cognitive impairment, and supports caregivers using evidence-based approaches. This funding opportunity aligns with the HBI Road Map Series (including the State & Local Road Map 2023–2027 and the Road Map for Indian Country) and fulfills the aims of the Building Our Largest Dementia (BOLD) Infra...

View Details

DoW Autism Clinical Trial Award

Open US HT942526ARPCTA

United States

Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.Distinctive Features: Applications are strongly encouraged to address one of the FY26 ARP Clinical Trial Award Areas of Inte...

View Details

Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)

Open US RFA-HD-27-012

United States

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. The purpose of this NOFO is to seek applications in a limited competition for the Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers (IDDRCs). This NOFO invites applications to undergo peer review for research center grants designed to advance the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities (IDD) and is limited to IDDRCs funded under RFA-HD-20-016 or RFA-HD-21-009. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) ...

View Details

DoW Epilepsy Virtual Post-Traumatic Epilepsy Research Center – Faculty Award

Open US HT942526ERPVPTERCF

United States

Summary: The fiscal year 2026 (FY26) Epilepsy Research Program (ERP) seeks to advance post-traumatic epilepsy (PTE) research through development of investigators new to the PTE field. To accomplish this, the ERP is soliciting Faculty members to join the Virtual Post-Traumatic Epilepsy Research Center (ViP-TERC). The ERP ViP-TERC is a unique, interactive virtual research center providing intensive mentoring, national networking, collaborations, and a peer group for new PTE investigators. The overarching goal of the ViP-TERC is to develop successful, highly productive PTE researchers in a collaborative research and career development environment to enhance quality and expand quantity of the PTE research field.Distinctive Features: This award mechanism focuses on both the Faculty member’s ...

View Details

Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)

Open US RFA-MH-27-135

United States

The purpose of this notice of funding opportunity (NOFO) is to elucidate the key components of the therapeutic effects of rapid-acting psychotropic interventional drugs (RAPIDs) by addressing the methodological challenges involved with these clinical trials. In addition, this NOFO seeks to advance understanding of how RAPIDs and adjunctive psychosocial interventions can be optimally delivered, monitored, and sustained over time to enhance effectiveness and generalizability. The NOFO will support studies designed to enhance the rigor of RAPID clinical trial design, which will ultimately increase the interpretability of the data and the generalizability of the results.

View Details

DoW Tuberous Sclerosis Complex, Exploration-Hypothesis Development Award

Open US HT942526TSCRPEHDA

United States

Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in the tuberous sclerosis complex (TSC) research field.Distinctive Features: Preliminary Data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.

View Details

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

Open US RFA-OD-27-005

United States

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. The purpose of this Notice of Funding Opportunity (NOFO) encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. The proposed research aims should be milestone-driven. The total project period for an application submitted in response to this NOFO may not exceed five years. This NOFO provides support for up to two years (R61 phase) for preliminary/developmental/planning studies, followed by possible transition to clinical trial support (R33)...

View Details

Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)

Open US RFA-DK-26-315

United States

This notice of funding opportunity (NOFO) invites applications designed to examine the efficacy and clinical effectiveness of multimodality digital health technology approaches to the remote management of diabetes.

View Details

Metastasis Research Network (U54 Clinical Trial Not Allowed)

Open US RFA-CA-27-012

United States

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. Overarching themes should encompass the interplay between at least two central elemen...

View Details

DoW, Ovarian Cancer, Pilot Award

Open US HT942526OCRPPA

United States

Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward.Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism.This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a co...

View Details

Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed)

Open US RFA-MH-27-205

United States

NIMH is announcing its intent to issue a single source cooperative agreement award to Brigham and Women"s Hospital to support continuation of the AMP® SCZ Data Processing, Analysis, and Coordination Center (DPACC). This allows DPACC to complete the processing and analysis of longitudinal multi-modal biomarker and clinical outcome data collected across 24 months.This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

View Details

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Open US PAR-27-073

United States

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship. Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and sharing of data and biospecimen resources as appropriate.

View Details

NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)

Open US RFA-CA-27-007

United States

This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human subject research study results through accrual in a variety of community settings. The purpose of NCORP is to engage cancer patient populations, those at risk of cancer, and organizations in rigorous studies focused on cancer control, prevention, treatment and care delivery.NCORP is a community-based research network that:Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials;Enha...

View Details

Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional)

Open US PAR-25-439

United States

The purpose of this initiative is to support the development of innovative research centers to foster nursing-led programs that promote community-partnered research to address persistent health challenges. Center applications developed in response to this RFA should propose strategies to strengthen the research infrastructure by establishing or expanding centralized research resources in School or College of Nursing (SON/CON), developing and enhancing nurse-led interdisciplinary teams, and building expertise in community-partnered research through conducting pilot research that applies NINR's research lenses. Center strategies should be informed by NINRs mission and should meaningfully engage the community throughout all activities.

View Details

DoW Melanoma Research Program Survivorship Research Award

Open US HT942526MRPSRA

United States

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity. Distinctive Features: · The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member and...

View Details

DoW Tick-Borne Disease Idea Development Award

Open US HT942526TBDRPIDA

United States

Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Idea Development Award (IDA) is to support conceptually innovative research that could lead to impactful discoveries or significant advancements that will accelerate progress toward reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or the quality of life. Applications should propose research that is conceptually innovative, introduces a new concept or question, challenges existing paradigms, approaches issues from a new perspective, or exhibits other uniquely creative qualities; and should not merely be a next logical step or an incremental advance on published data or ongoing research. Distinctive Features: A Career Developmen...

View Details

Community Health Aide Program: Tribal Planning and Implementation (TPI)

Open US HHS-2026-IHS-TPI-0001

United States

The Community Health Aide Program (CHAP) Tribal Planning and Implementation (TPI) grant empowers Tribes and Tribal Organizations (T/TO) in the contiguous 48 states to plan and implement CHAP by providing regional flexibility, clinical support, tailored healthcare solutions, technological infrastructure, comprehensive training, integration strategies, and addressing social determinants of health.

View Details

DoW Traumatic Brain Injury and Psychological Health, Translational Research Award

Open US HT942526TBIPHRPTRA

United States

Summary: The Translational Research Award (TRA) intends to accelerate the conversion of scientific findings into impactful clinical applications. The TRA prioritizes innovative approaches over purely iterative or incremental research. Submissions focusing on minor modifications to existing standards without the intent or potential to significantly improve clinical care or patient outcomes do not meet the intent of the mechanism.Distinctive Features: Basic research and clinical trials are prohibited. Preliminary data are required.· For animal research, applications must describe the choice of model and its relevance to the human clinical condition.· For research prospectively enrolling human sub...

View Details

NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

Open US PAR-25-333

United States

The purpose of the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) program is to develop and maintain a strong cohort of independently funded dentist scientists dedicated to improving dental, oral and craniofacial health. This program is designed to facilitate a timely transition of outstanding dual degree dentist scientists from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions by providing support for two years of mentored training and three to five years of independent research. An option for five years of independent (R00) support is available to accommodate clinical training in a dental specialty program at no more than 3 person-months effort (25% full-time professional effort) in any year of the R00 p...

View Details

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Open US PAR-25-446

United States

The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. This includes preclinical and clinical research studies that will have high impact and quickly yield the necessary results to advance candidate interventions closer to regulatory approval or clinical adoption. This NOFO will utilize the UG3/UH3 activity code.

View Details

Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)

Open US RFA-DK-26-309

United States

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) of the U.S. Department of Health and Human Services is seeking a Single Source renewal application to continue scientific service as the Scientific and Data Coordination Center for the Liver Cirrhosis Network.The application will be peer-reviewed and if it is not a meritorious application, it will not be funded. This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for fund...

View Details

DoW Lupus, Transformative Vision Development Award

Open US HT942526LRPTVDA

United States

Summary: This funding mechanism supports planning and development activities and pilot studies that will generate preliminary data and demonstrate feasibility for achieving the aims of a future interventional study. Successful studies may be submitted to a future Lupus Research Program (LRP) Transformative Vision Award (TVA), or equivalent, for funding consideration (See Funding Opportunity Number HT942526LRPTVA for additional information). Research must address at least one of the fiscal year 2026 (FY26) LRP Transformative Vision Development Award (TVDA) focus areas. This funding mechanism allows for phase 0/1 clinical trials, if appropriate. The mechanism does not allow for phase 2/3 clinical trials or animal studies.Distinctive Features:• Preliminary data are permitted but not requir...

View Details

Primary Care Dental Faculty Development Center Program (PCDFD)

Open US HRSA-26-080

United States

The Primary Care Dental Faculty Development Center serves as a resource and training hub to:Support the development of faculty who teach primary care dentistry. Advance community and population-level approaches to assess and improve oral health outcomes. Prepare dental faculty for roles in program leadership. Faculty development will include: increasing the ability to teach clinical dentistry, developing leadership competencies, and dissemination including publishing and presentations.

View Details

Continuing Human Enabling Enhancing Restoring and Sustaining

Open US FA238424S2233

United States

The Air Force Research Laboratory, Human Effectiveness Directorate (AFRL/RH) and the United States Air Force School of Medicine (USAFSAM) CHEERS Multiple Authority Announcement (MAA) is intended to provide a comprehensive strategy for AFRL/RH and USAFSAM's range of Science and Technology (S&T) requirements, allowing for progression from basic research to technology maturation and transition.20 Nov 2025: Amendment 01 - Annual UpdateThe CHEERS Multiple Authority Announcement (MAA) MUST be reviewed in tandem with the solicitations in order to have access to all applicable attachments and instructions. There are three (3) open, 2-step, solicitations currently accepting white papers. Please see below for solicitation numbers.Multiple Authority Announcement (MAA), Notice FA238424S223...

View Details

Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)

Open US PAR-25-449

United States

The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for research on how mind and body interventions through psychological and/or physical inputs (e.g., mindfulness meditation, yoga, acupuncture, massage, and other brain and/or body based interventions) impact mechanisms of emotional well-being (EWB) and their associations with whole person health (WPH), consistent with the NIH priority to address the health needs of the American people and improve their well-being. The NOFO will support rigorous and well-powered mechanistic research studies that are supported by strong preliminary data. The studies should examine the effects of mind and body interventions on innovative mechanisms of EWB (as the ...

View Details

Frequently Asked Questions

Who buys healthcare tenders?

National ministries of health, public hospitals, WHO, UNICEF Supply Division, Global Fund, Gavi, and bilateral health programmes (e.g. PEPFAR, GIZ Health).

What certifications are typical for medical device tenders?

ISO 13485, CE mark, FDA 510(k), WHO prequalification for key categories, and country-specific regulatory approval (SAHPRA, NAFDAC, MHRA, etc.).

How do pharma tenders typically structure framework agreements?

Most are 1–3 year framework agreements with volume-based pricing tiers, local manufacturing or distribution commitments, and pharmacovigilance obligations.

Healthcare & Medical Tenders & Grants

Who this is for

Top Funders

Get Healthcare & Medical Alerts